Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $737.72M.
ENTERPRISE VALUE (EV)
$737.72M
Monte Rosa Therapeutics, Inc.
Market Cap
$832.81M
Enterprise Value (EV)
$737.72M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | $832.81M | $737.72M |
| Beta Bionics, Inc. (BBNX)vs › | $830.51M | $792.70M |
| Alumis Inc. (ALMS)vs › | $830.36M | $803.09M |
| Pacific Biosciences of California, Inc. (PACB)vs › | $829.31M | $1.47B |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $845.45M | $623.93M |
| QuidelOrtho Corporation (QDEL)vs › | $848.98M | $3.80B |
| SL Science Holding Ltd (SLBT)vs › | $857.96M | $856.92M |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $859.24M | $838.37M |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $860.24M | $842.07M |
| SI-BONE, Inc. (SIBN)vs › | $861.04M | $835.08M |
Market Cap
$832.81M
Total Debt
$34.79M
Cash
$129.88M
Enterprise Value
$737.72M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
